Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor

This publication has 12 references indexed in Scilit:

• Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases
  Current Topics in Medicinal Chemistry, 2005
• N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent
  Journal of Medicinal Chemistry, 2004
• In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)
  International Journal of Cancer, 2002
• Mammalian G1 cyclins
  Cell, 1993
• Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation
  Trends in Biochemical Sciences, 1990
• G ₁ Events and Regulation of Cell Proliferation
  Science, 1989
• Pyrazolo[3,4-b]pyridines: Syntheses, reactions, and nuclear magnetic resonance spectra
  Canadian Journal of Chemistry, 1988
• Synthesis of functionalized styrenes via palladium-catalyzed coupling of aryl bromides with vinyl tin reagents
  The Journal of Organic Chemistry, 1987
• The Palladium‐Catalyzed Cross‐Coupling Reactions of Organotin Reagents with Organic Electrophiles [New Synthetic Methods (58)]
  Angewandte Chemie International Edition, 1986
• Ozonolysis of Vinylpyridines
  The Journal of Organic Chemistry, 1961